Caris Life Sciences Ownership | Who Owns Caris Life Sciences?

Overview Forecast RevenueFinancials Chart Transcripts

Caris Life Sciences Ownership Summary

Caris Life Sciences is owned by 0.93% institutional investors, 48.54% insiders, and 50.53% retail investors. Fmr is the largest institutional shareholder, holding 1.84% of CAI shares. Fidelity Select Health Care is the top mutual fund, with 1.27% of its assets in Caris Life Sciences shares.

CAI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Caris Life Sciences	0.93%	48.54%	50.53%
Sector	Healthcare Stocks	35.75%	11.89%	52.37%
Industry	Biotech Stocks	36.05%	11.82%	52.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	30.79M	1.84%	$550.45M
J. h. whitney equity partners vi	18.26M	1.09%	$326.43M
Point72 (difc)	654.79K	1.01%	$19.81M
Sixth street partners management company	14.39M	0.86%	$257.21M
First light asset management	403.92K	0.62%	$11.88M
Coatue management	9.82M	0.59%	$175.58M
Braidwell lp	8.01M	0.48%	$143.21M
Pointstate capital lp	7.36M	0.44%	$131.60M
T. rowe price investment management	5.59M	0.33%	$99.92M
Blackrock funding, inc. /de	4.86M	0.29%	$86.85M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
J. h. whitney equity partners vi	18.26M	100.00%	$326.43M
Sixth street partners management company	14.39M	36.19%	$257.21M
Pura vida investments	89.94K	10.81%	$1.61M
Braidwell lp	8.01M	4.78%	$143.21M
Pointstate capital lp	7.36M	1.67%	$131.60M
Point72 (difc)	654.79K	1.30%	$19.81M
First light asset management	403.92K	1.12%	$11.88M
Duquesne family office	1.89M	1.00%	$33.87M
Orbimed advisors	2.81M	1.00%	$50.19M
Sandia investment management lp	8.60K	0.78%	$260.15K

Top Buyers

Holder	Shares	% Assets	Change
Fmr	30.79M	0.03%	16.57M
Blackrock funding, inc. /de	4.86M	0.00%	2.49M
Los angeles capital management	2.29M	0.16%	2.29M
Duquesne family office	1.89M	1.00%	1.89M
Capital world investors	1.18M	0.00%	1.18M

Top Sellers

Holder	Shares	% Assets	Change
Silver lake group	-	-	-5.29M
Sixth street partners management company	14.39M	36.19%	-5.00M
T. rowe price investment management	5.59M	0.07%	-3.62M
Citadel advisors	77.81K	0.00%	-3.04M
Millennium management	1.53M	0.01%	-2.12M

New Positions

Holder	Shares	% Assets	Change	Value
Duquesne family office	1.89M	1.00%	1.89M	$33.87M
Capital world investors	1.18M	0.00%	1.18M	$21.10M
Arrowstreet capital, limited partnership	210.59K	0.00%	210.59K	$3.77M
Norges bank	110.29K	0.00%	110.29K	$2.98M
Vanguard fiduciary trust	96.58K	0.00%	96.58K	$1.73M

Sold Out

Holder	Change
Tortoise investment management	-1.00
Nomura asset management	-562.00
Cx institutional	-684.00
Daiwa securities group	-850.00
Amalgamated bank	-1.47K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	77	-60.31%	15,582,500	-89.27%	-	0.04%	63	-54.01%	7	-78.79%
Dec 31, 2025	101	-30.82%	24,811,123	-78.12%	8	0.54%	78	-22.77%	12	-40.00%
Sep 30, 2025	46	-61.02%	8,557,378	-92.17%	13	0.05%	38	-67.80%	5	-
Jun 30, 2025	117	-	106,907,974	-	616	-	117	-	-	-
Dec 31, 2021	1	-99.25%	1,399	-99.99%	-	0.00%	-	-100.00%	-	-100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Select Health Care	3.60M	1.27%	320.00K
Vanguard Total Stock Mkt Idx Inv	3.17M	1.12%	10.05K
Fidelity Select Medical Tech and Devcs	3.00M	1.06%	150.00K
JPMorgan Mid Cap Growth I	2.93M	1.04%	1.24M
Strategic Advisers Fidelity US TtlStk	2.87M	1.01%	290.00K
Fidelity Contrafund	2.72M	0.96%	389.92K
T. Rowe Price US Mid-Cap Growth Equity	2.70M	0.96%	-2.30K
T. Rowe Price Mid-Cap Growth	2.70M	0.96%	-1.17K
Fidelity VIP Mid Cap Initial	2.69M	0.95%	-
Vanguard Small Cap Index	2.27M	0.80%	-9.17K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 11, 2026	Vacirca Jeff L	-	Buy	$501.43K
Dec 11, 2025	Power Luke Thomas	See Remarks	Sell	$1.62M
Dec 11, 2025	Power Luke Thomas	See Remarks	Sell	$38.02K
Nov 07, 2025	Denton John Russel	See Remarks	Buy	$100.79K
Nov 07, 2025	Spetzler David Baxley	President	Buy	$9.54K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	1	-
2026 Q1	-	-
2025 Q4	2	2
2021 Q4	-	-
2021 Q2	-	-

CAI Ownership FAQ

Who Owns Caris Life Sciences?

Caris Life Sciences shareholders are primarily institutional investors at 0.93%, followed by 48.54% insiders and 50.53% retail investors. The average institutional ownership in Caris Life Sciences's industry, Biotech Stocks , is 36.05%, which Caris Life Sciences falls below.

Who owns the most shares of Caris Life Sciences?

Caris Life Sciences’s largest shareholders are Fmr (30.79M shares, 1.84%), J. h. whitney equity partners vi (18.26M shares, 1.09%), and Point72 (difc) (654.79K shares, 1.01%). Together, they hold 3.94% of Caris Life Sciences’s total shares outstanding.

Does Blackrock own Caris Life Sciences?

BlackRock is not among the top 10 institutional shareholders of Caris Life Sciences.

Who is Caris Life Sciences’s biggest shareholder by percentage of total assets invested?

J. h. whitney equity partners vi is Caris Life Sciences’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 18.26M Caris Life Sciences shares, valued at 326.43M$.

Who is the top mutual fund holder of Caris Life Sciences shares?

Fidelity Select Health Care is the top mutual fund holder of Caris Life Sciences shares, with 1.27% of its total shares outstanding invested in 3.6M Caris Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools